Meet Ed Dybka, General Manager, Ipsen Canada

Ed Dybka was appointed to the role of General Manager at Ipsen Biopharmaceuticals Canada Inc. in October 2018.  In this role, he is responsible for overseeing all of Ipsen’s operations across all therapeutic areas in Canada. Ed is a member of the Ipsen North America Leadership Team and the Ipsen Global Leadership Team.


Ipsen Group

With products sold in over 115 countries, and offices in more than 30 countries, the Ipsen Group is a global specialty-driven biotechnology company that is focused on putting patients first.

Ipsen in Canada

Ipsen Canada brings a refreshing approach to innovation, research, and patient support to the Canadian pharmaceutical market. In the span of a few years, we have helped bring important medicines to Canadians living with rare and serious diseases, where limited options exist.


Our History

Our roots in Canada are relatively young – but Ipsen’s beginnings can be traced all the way back to 1929.

Strategic Vision

At Ipsen Canada, our ambition is to make medicines that make a difference; and to keep doing that, year in, year out. By working closely with like-minded industry partners, we will bring to market therapies that truly make a difference.

Last update 15/10/2018